Conference Coverage

Recent advances in our understanding of the pathophysiology of asthma have led to improved control, particularly for those patients with moderate-to-severe disease who remain uncontrolled after receiving traditional asthma therapies. Keeping pace with these guidelines and emerging data from major conferences can quickly become overwhelming, so to help healthcare professionals stay up to date, this expert discussion reviews key data presented at CHEST 2019.

Learn more about the mission of the Lurie Cancer Center’s Lynn Sage Breast Cancer Symposium and the topics featured at the 2019 conference from Dr. William Gradishar, who’s served as the Chair of the Lynn Sage Breast Cancer Symposium since its inception in 1998.

Tune in to hear Dr. William Gradishar break down his presentations as well as other highlights attendees can look forward to at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois.

Joining Dr. Matt Birnholz at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, is Dr. Jonathan Strauss to discuss the talks he’s given at this year’s conference on the evolution of radiation oncology as a field, challenging breast cancer cases, and emerging factors that support the emission of radiotherapy in invasive cancers.

Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

At the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Matt Birnholz caught up with Kelly Scheu, a nurse practitioner specializing in breast oncology at the University of Michigan, who shared how her spirituality and medical expertise of 27 years in the oncology field blend to enhance breast cancer care.

Tune in as Dr. Matt Birnholz talks with Thanos Kosmidis, the founder and CEO of Care Across, about the company’s new poster presentation on breast cancer patients’ quality of life at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

Joining Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about his recent study titled, Agreement Between Patients and Oncologists on the Severity of the Patient’s Symptoms and Functions During a One-Year Follow-Up After Breast Cancer Treatment, is Dr. Randi Reidunsdatter.

The European Society of Medical Oncology (ESMO) Congress is held each year to bring together clinicians and researchers from all over the world, and at this year’s conference, new and emerging breast cancer treatments took center stage. Tune in as Dr. Matt Birnholz recaps those advances on the ESMO Congress floor in Barcelona, Spain.